We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+13.47%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$4.57B
AUM Growth
+$321M
Cap. Flow
-$161M
Cap. Flow %
-3.53%
Top 10 Hldgs %
17.11%
Holding
760
New
56
Increased
232
Reduced
366
Closed
49

Sector Composition

Rank Sector Weight
1 Technology 23.18%
2 Healthcare 12.25%
3 Communication Services 11.33%
4 Industrials 11.13%
5 Financials 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
51
Pfizer
PFE
$143B
$26M 0.57%
699,982
-510
-0.1% -$18.2K
MSGS icon
52
Madison Square Garden
MSGS
$9.59B
$25.2M 0.55%
120,140
-12,343
-9% -$2.42M
WWE
53
DELISTED
World Wrestling Entertainment
WWE
$24.8M 0.54%
383,063
-29,740
-7% -$1.88M
GOOG icon
54
Alphabet (Google) Class C
GOOG
$4.11T
$24.8M 0.54%
371,500
+2,740
+0.7% +$177K
QQQ icon
55
Invesco QQQ Trust
QQQ
$436B
$24.2M 0.53%
113,595
+6,433
+6% +$1.29M
FORM icon
56
FormFactor
FORM
$6.51B
$23.8M 0.52%
916,260
-80,840
-8% -$1.82M
HON icon
57
Honeywell
HON
$76.4B
$23.5M 0.52%
141,079
+1,485
+1% +$243K
AEIS icon
58
Advanced Energy
AEIS
$10.1B
$23.3M 0.51%
326,543
+111,695
+52% +$6.95M
GOOGL icon
59
Alphabet (Google) Class A
GOOGL
$4.12T
$22.8M 0.5%
340,220
+800
+0.2% +$51.6K
RHI icon
60
Robert Half
RHI
$4.11B
$22.5M 0.49%
356,964
-33,380
-9% -$1.94M
ICPT
61
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$21.6M 0.47%
174,293
-16,895
-9% -$1.51M
BAC icon
62
Bank of America
BAC
$429B
$21.5M 0.47%
610,886
-10,286
-2% -$332K
VZ icon
63
Verizon
VZ
$197B
$20.7M 0.45%
336,575
+4,197
+1% +$253K
AVAV icon
64
AeroVironment
AVAV
$7.19B
$20.3M 0.44%
328,607
+16,867
+5% +$1.01M
SCZ icon
65
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.1B
$20.1M 0.44%
322,774
+598
+0.2% +$35.9K
WERN icon
66
Werner Enterprises
WERN
$2.2B
$20.1M 0.44%
552,316
-61,905
-10% -$2.26M
FARO
67
DELISTED
Faro Technologies
FARO
$19.7M 0.43%
390,414
+152,700
+64% +$7.46M
BMY icon
68
Bristol-Myers Squibb
BMY
$129B
$19.6M 0.43%
305,382
+66,303
+28% +$3.8M
VSH icon
69
Vishay Intertechnology
VSH
$4.6B
$19.3M 0.42%
905,011
-66,991
-7% -$1.3M
ESPR
70
DELISTED
Esperion Therapeutics
ESPR
$18.8M 0.41%
315,889
+72,560
+30% +$3.26M
VIAV icon
71
Viavi Solutions
VIAV
$7.95B
$18.8M 0.41%
1,250,206
+124,035
+11% +$1.86M
LASR icon
72
nLIGHT
LASR
$3.33B
$18.6M 0.41%
918,379
+47,830
+5% +$825K
MDCO
73
DELISTED
Medicines Co
MDCO
$18.2M 0.4%
214,014
-229,580
-52% -$15.3M
LAZ icon
74
Lazard
LAZ
$3.96B
$18.1M 0.4%
453,673
-49,339
-10% -$1.86M
QUAL icon
75
iShares MSCI USA Quality Factor ETF
QUAL
$45.7B
$17.3M 0.38%
170,839
+8,545
+5% +$823K

Similar funds

Pinnacle Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Pinnacle Associates held 760 positions worth $4.57B, up 7.6% from $4.25B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Pinnacle Associates withdrew a net $161M in Q4 2019, closing 49 positions and reducing 366 holdings. Its most notable exit was Alder Biopharmaceuticals, an estimated $17M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Pinnacle Associates opened a new position in Plug Power worth $8.49M.

  • Pinnacle Associates's largest Q4 2019 buy was Plug Power: 2,687,823 shares worth $8.49M.
  • Pinnacle Associates added most to Coherent in Q4 2019, an estimated $13.4M increase.
  • Pinnacle Associates's biggest Q4 2019 reduction was Apple, cutting an estimated $23.4M.
  • Pinnacle Associates fully exited Alder Biopharmaceuticals in Q4 2019, selling an estimated $17M.
  • Pinnacle Associates's ten largest holdings make up 17% of its $4.57B portfolio in Q4 2019.
  • Pinnacle Associates opened 56 new positions and closed 49 in Q4 2019.
  • Pinnacle Associates's portfolio value rose 7.6% quarter-over-quarter to $4.57B.

Based on Pinnacle Associates's 13F filing for Q4 2019, filed 3 Feb 2020.